News | April 25, 2014

Ultrasound Study Finds Astronauts’ Hearts Become More Spherical in Space

Findings may benefit certain cardiovascular patients on Earth, too

ACC.14 Astronauts Clinical Trial Cardiovascular Ultrasound

April 25, 2014 — New findings from a clinical study of 12 astronauts show the heart becomes more spherical when exposed to long periods of microgravity in space, a change that could lead to cardiac problems, according to research to be presented at the American College of Cardiology’s 63rd Annual Scientific Session.

With implications for an eventual manned mission to Mars, the findings represent an important step toward understanding how a spaceflight of 18 months or more could affect astronauts’ heart health.

“The heart doesn’t work as hard in space, which can cause a loss of muscle mass,” said James Thomas, M.D., Moore Chair of cardiovascular imaging and lead scientist for ultrasound at NASA, and senior author of the study. “That can have serious consequences after the return to Earth, so we’re looking into whether there are measures that can be taken to prevent or counteract that loss.”

The researchers say that knowing the amount and type of exercise astronauts need to perform to keep the heart healthy is going to be very important to guarantee their safety on a long flight like a mission to Mars. Thomas added that exercise regimens developed for astronauts could also be used to help maintain heart health in people on Earth who have severe physical limitations, such as people on extended bed rest or those with heart failure regime.

The research team trained astronauts to take images of their hearts using ultrasound machines installed on the International Space Station. Twelve astronauts participated, providing data on heart shape before, during and after spaceflight.

The results show the heart in space becomes more spherical by a factor of 9.4 percent, a transformation similar to what scientists had predicted with sophisticated mathematical models developed for the project. By validating those models, the study could also lead to a better understanding of common cardiovascular conditions in patients on Earth.

“The models predicted the changes we observed in the astronauts almost exactly. It gives us confidence that we can move ahead and start using these models for more clinically important applications on Earth, such as to predict what happens to the heart under different stresses,” Thomas said.

The team is now working to generalize the models to analyze such conditions as ischemic heart disease, hypertrophic cardiomyopathy and valvular heart disease.

“The models could help us simulate those pathologies to understand the impact on cardiac function,” Thomas said.

The astronauts’ more spherical heart shape appears to be temporary, with the heart returning to its normal elongated shape shortly after the return to Earth. The more spherical shape experienced in space may mean the heart is performing less efficiently, although the long-term health effects of the shape change are not known.

Spaceflight is known to cause a variety of cardiac effects. Upon return to Earth, astronauts commonly become lightheaded or pass out in a condition known as orthostatic hypotension, in which the body experiences a sudden drop in blood pressure when standing up. Arrhythmias have also been observed during space travel, and there is concern that the radiation astronauts are exposed to in space may accelerate atherosclerosis. The research team is continuing to examine these and other potential cardiovascular effects.

This study is funded by the National Space Biomedical Research Institute through NASA Cooperative Agreement NCC9-58.

For more information: www.CardioSource.org.

Related Content

New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
Overlay Init